# RESET® Obesity — Op. Dr. Murat Üstün

> RESET® is the world's first endoscopic duodenal device therapy for obesity and type 2 diabetes. Non-surgical, reversible, and CE-approved.

## About RESET® Therapy

RESET® (Duodenal Mucosal Resurfacing via Endoscopic Sleeve) is a minimally invasive, endoscopic procedure developed by Morphic Medical. It is inserted and removed entirely through the mouth — no surgery, no incisions, no general anesthesia required.

The device is a flexible polymer sleeve that lines the duodenum (first part of the small intestine) and mimics aspects of a gastric bypass by preventing food from contacting the duodenal wall, thereby improving metabolic signaling.

**Key clinical results:**
- 17–19% Total Body Weight Loss
- 1.9% reduction in HbA1c (blood sugar control)
- 77% durability at 12 months
- CE Mark approved medical device

## Who performs the procedure?

**Op. Dr. Murat Üstün** — Bariatric and metabolic endoscopist, Liv Vadi Hospital (Vadistanbul), Istanbul, Turkey.

Contact:
- Phone (Turkey): +90 532 413 1143
- Phone (UK): +44 7491 068686
- Email: drmuratustun@gmail.com
- WhatsApp: https://wa.me/+905324131143

## Pages

- [Home](https://resetobesity.com/) — Overview of RESET® therapy
- [RESET® Therapy](https://resetobesity.com/reset) — Full clinical detail, mechanism, candidates
- [Clinical Trials](https://resetobesity.com/clinical-trials) — STEP-1 trial, eligibility, hospital sites
- [Clinical Publications](https://resetobesity.com/clinical-publications) — Peer-reviewed research
- [Contact](https://resetobesity.com/contact) — Appointment booking, location

## Full content

See [/llms-full.txt](https://resetobesity.com/llms-full.txt) for the complete content of all pages.